The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review

Long-acting muscarinic receptor antagonists (LAMAs) are the cornerstone for the treatment of chronic obstructive pulmonary disease (COPD); furthermore, tiotropium is approved as add-on therapy in severe asthmatic patients. Accumulating evidence suggests that LAMAs may modulate airway contractility a...

Descripción completa

Detalles Bibliográficos
Autores principales: Calzetta, Luigino, Coppola, Angelo, Ritondo, Beatrice Ludovica, Matino, Matteo, Chetta, Alfredo, Rogliani, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886086/
https://www.ncbi.nlm.nih.gov/pubmed/33603353
http://dx.doi.org/10.2147/COPD.S285867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886086/
https://www.ncbi.nlm.nih.gov/pubmed/33603353
http://dx.doi.org/10.2147/COPD.S285867

Ejemplares similares